NFKB1 and lung carcinoma: Recently, our group has reported that MAPK15-mediated NF-κB activation enhances the arsenic trioxide-induced apoptosis through promoting the phosphorylation and degradation of IκBα, as well as the nuclear translocation of NF-κB in lung cancer cells [15].